
Chris Fielding summarises a Welsh cohort study which finds that neurodevelopmental and mental disorders are linked to school absenteeism and exclusion.
[read the full story...]Chris Fielding summarises a Welsh cohort study which finds that neurodevelopmental and mental disorders are linked to school absenteeism and exclusion.
[read the full story...]SmokingAndMentalHealth – Carolyn Chew-Graham summarises the conversations that took place at the Smoking and Mental Health webinar on 28th September 2022.
[read the full story...]Ian Hamilton summarises a recent study exploring whether psychotic-like experiences are related to the discontinuation of cannabis consumption in young adults.
[read the full story...]In his debut blog, Joseph Schwartz explores a systematic review finding that a range of psychiatric disorders are associated with an elevated risk of violence.
[read the full story...]In his debut blog, Andrew Steptoe summarises two recent papers using electronic health record datasets, which suggest that having a psychiatric diagnosis may put people at risk of COVID-19 infection.
[read the full story...]Raphael Underwood summarises a recent umbrella review (a synthesis of meta-analyses), which aimed to evaluate the current literature regarding childhood sexual abuse and long-term outcomes (psychosocial outcomes, psychiatric diagnoses and physical health outcomes).
[read the full story...]Sarah Carr explores a recent cross-sectional study on sexual minority status and symptoms of psychosis, which looks at the role of bullying, discrimination, social support and drug use.
[read the full story...]Ian Hamilton summarises the recently published CIRCLE trial, which looks at the clinical and cost-effectiveness of contingency management for cannabis use in early psychosis.
[read the full story...]Luke Sheridan-Reins explores a recent paper on the contribution of cannabis use to variation in the incidence of psychotic disorder across Europe.
[read the full story...]David Shiers and Peter Byrne summarise the new SCIMITAR+ trial out today in The Lancet Psychiatry, which evaluates a bespoke smoking cessation intervention for people with severe mental illness.
[read the full story...]